Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 11, 1998

View Archived Issues

Flamels Genvir For Herpes Shows Strong Phase III Data

Stanford Rook Changes Name, Starts Cancer Drugs Phase III

Biomira, Plant Vaccine Firm Partner For Cancer Compounds

Adult Tooth Replacement By Gene Expression Could Be Wave Of Dental Future

Agis Buys Stake In Pharmos, Becomes Largest Shareholder

Trinity Biotech Earnings Up; HIV Test Marketing Expands

U.K. Officials, Insurers Join To Validate Genetic Testing

Phytopharm, Heska Sign Deal Covering Botanical Pet Drugs

Treatment Of Blood Clots Explored By Two Groups

Cambridge Antibodys RA Drug Proving Effective In Early Data

Other News To Note

BioVision Aims To Bridge Japanese, U.S. Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...